Ghrelin and its therapeutic potential for cachectic patients

Peptides

Volumn 30, Issue 10, 2009, Pages 1951-1956

  Ashitani, Jun ichi ^a   Matsumoto, Nobuhiro ^a   Nakazato, Masamitsu ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Cachexia; Clinical trial; Ghrelin

Indexed keywords

ADIPONECTIN; GHRELIN; GROWTH HORMONE; GROWTH HORMONE SECRETAGOGUE RECEPTOR; LEPTIN; OBESTATIN; PEPTIDE YY; PLACEBO; SOMATOMEDIN C; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 3;

ANOREXIA; ANTIINFLAMMATORY ACTIVITY; APPETITE; CACHEXIA; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; ENERGY BALANCE; GROWTH HORMONE RELEASE; HORMONE ACTION; HUMAN; LEAN BODY WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE DRUG DOSE;

ANIMALS; APPETITE; APPETITE REGULATION; CACHEXIA; CLINICAL TRIALS AS TOPIC; FEEDING BEHAVIOR; GHRELIN; HUMANS;

ANIMALIA;

EID: 70349311434     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.07.002     Document Type: Review

References (79)

1. Akamizu T., Iwakura H., Ariyasu H., Hosoda H., Murayama T., Yokode M., et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol 158 (2008) 491-498
2. Akamizu T., Iwakura H., Ariyasu H., Murayama T., Sumi E., Teramukai S., et al. Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia. J Am Geriatr Soc 56 (2008) 2363-2365
3. Akamizu T., Takaya K., Irako T., Hosoda H., Teramukai S., Matsuyama A., et al. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol 150 (2004) 447-455
4. Akashi Y.J., Springer J., and Anker S.D. Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches. Curr Heart Fail Rep 2 (2005) 198-203
5. Andreyev H.J., Norman A.R., Oates J., and Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 34 (1998) 503-509
6. Arbeiter A.K., Büscher R., Petersenn S., Hauffa B.P., Mann K., and Hoyer P.F. Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation. Nephrol Dial Transplant 24 (2009) 643-646
7. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86 (2001) 4753-4758
8. Arvat E., Di Vito L., Broglio F., Papotti M., Muccioli G., Dieguez C., et al. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 23 (2000) 493-495
9. Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M.A., et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 52 (2003) 947-952
10. Asakawa A., Inui A., Fujimiya M., Sakamaki R., Shinfuku N., Ueta Y., et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54 (2005) 18-24
11. Bai A., Lu N., Guo Y., Chen J., and Liu Z. Modulation of inflammatory response via alpha2-adrenoceptor blockade in acute murine colitis. Clin Exp Immunol 156 (2009) 353-362
12. Binn M., Albert C., Gougeon A., Maerki H., Coulie B., Lemoyne M., et al. Ghrelin gastrokinetic action in patients with neurogenicgastroparesis. Peptides 27 (2007) 1603-1606
13. Broglio F., Benso A., Castiglioni C., Gottero C., Prodam F., Destefanis S., et al. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab 88 (2003) 1537-1542
14. Chung H., Kim E., Lee D.H., Seo S., Ju S., Lee D., et al. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 148 (2007) 148-159
15. Cittadini A., Grossman J.D., Napoli R., Katz S.E., Strömer H., Smith R.J., et al. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol 29 (1997) 1109-1116
16. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., and Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50 (2001) 1714-1719
17. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123 (2002) 1120-1128
18. DeBoer M.D., Zhu X., Levasseur P.R., Inui A., Hu Z., Han G., et al. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 149 (2008) 827-835
19. DeBoer M.D., Zhu X.X., Levasseur P., Meguid M.M., Suzuki S., Inui A., et al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 148 (2007) 3004-3012
20. De Martel C., Haggerty T.D., Corley D.A., Vogelman J.H., Orentreich N., and Parsonnet J. Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol 102 (2007) 1166-1172
21. Dec G.W., and Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 331 (1994) 1564-1575
22. Dewys W.D., Begg C., Lavin P.T., Band P.R., Bennett J.M., Bertino J.R., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69 (1980) 491-497
23. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114 (2004) 57-66
24. Duxbury M.S., Waseem T., Ito H., Robinson M.K., Zinner M.J., Ashley S.W., et al. Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem Biophys Res Commun 309 (2003) 464-468
25. Garcia J.M., Cata J.P., Dougherty P.M., and Smith R.G. Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia. Endocrinology 149 (2008) 455-460
26. Garcia J.M., Garcia-Touza M., Hijazi R.A., Taffet G., Epner D., Mann D., et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 90 (2005) 2920-2926
27. Garcia J.M., Boccia R.V., Graham C., Kumor K., and Polvino W. A phase II, randomized, placebo-controlled, double blind study of the efficacy and safety of RC-1291 for the treatment of cancer-cachexia. J Clin Oncol 25 (2007) S25 [abstract]
28. Ghè C., Cassoni P., Catapano F., Marrocco T., Deghenghi R., Ghigo E., et al. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology 143 (2002) 484-491
29. Gonzalez-Rey E., Chorny A., and Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 130 (2006) 1707-1720
30. Granado M., Priego T., Martín A.I., Villanúa M.A., and López-Calderón A. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab 288 (2005) 486-492
31. Hanada T., Toshinai K., Kajimura N., Nara-Ashizawa N., Tsukada T., Hayashi Y., et al. Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem Biophys Res Commun 301 (2003) 275-279
32. Houck W.V., Pan L.C., Kribbs S.B., Clair M.J., McDaniel G.M., Krombach R.S., et al. Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure. Circulation 100 (1999) 2003-2009
33. Huang Q., Fan Y.Z., Ge B.J., Zhu Q., and Tu Z.Y. Circulating ghrelin in patients with gastric or colorectal cancer. Dig Dis Sci 52 (2007) 803-809
34. Itoh T., Nagaya N., Yoshikawa M., Fukuoka A., Takenaka H., Shimizu Y., et al. Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 (2004) 879-882
35. Jeon T.Y., Lee S., Kim H.H., Kim Y.J., Son H.C., Kim D.H., et al. Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab 89 (2004) 5392-5396
36. King R.M., Pairolero P.C., Trastek V.F., Payne W.S., and Bernatz P.E. Esophagogastrectomy for carcinoma of the esophagus: early and late functional results. Ann Thorac Surg 44 (1987) 119-122
37. Kodama T., Ashitani J., Matsumoto N., Kangawa K., and Nakazato M. Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulm Pharmacol Ther 21 (2008) 774-779
38. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
39. Langhans W. Peripheral mechanisms involved with catabolism. Curr Opin Clin Nutr Metab Care 5 (2002) 419-426
40. Le Corvoisier P., Hittinger L., Chanson P., Montagne O., Macquin-Mavier I., and Maison P. Cardiac effects of growth hormone treatment in chronic heart failure: a meta-analysis. J Clin Endocrinol Metab 92 (2007) 180-185
41. Le Roux C.W., Neary N.M., Halsey T.J., Small C.J., Martinez-Isla A.M., Ghatei M.A., et al. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 90 (2005) 4521-4524
42. Li W.G., Gavrila D., Liu X., Wang L., Gunnlaugsson S., Stoll L.L., et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 109 (2004) 2221-2226
43. Masuda Y., Tanaka T., Inomata N., Ohnuma N., Tanaka S., Itoh Z., et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 276 (2000) 905-908
44. Mori M., Suzuki H., Masaoka T., Imaeda H., Nomoto Y., Hosoda H., et al. Intravenous ghrelin administration enhances gastric acid secretion-evaluation using wireless pH capsule. Aliment Pharmacol Ther 24 (2006) 905-908
45. Morley J.E. Weight loss in older persons: new therapeutic approaches. Curr Pharm Des 13 (2007) 3637-3647
46. Morley J.E., Thomas D.R., and Wilson M.M. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83 (2006) 735-743
47. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., and Schwartz M.W. Central nervous system control of food intake and body weight. Nature 443 (2006) 289-295
48. Müller M.J., Loyal S., Schwarze M., Lobers J., Selberg O., Ringe B., et al. Resting energy expenditure and nutritional state in patients with liver cirrhosis before and after liver transplantation. Clin Nutr 13 (1999) 145-152
49. Murata M., Okimura Y., Iida K., Matsumoto M., Sowa H., Kaji H., et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 277 (2002) 5667-5674
50. Murray C.D., Martin N.M., Patterson M., Taylor S.A., Ghatei M.A., Kamm M.A., et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 54 (2005) 1693-1698
51. Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 128 (2005) 1187-1193
52. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280 (2001) 1483-1487
53. Nagaya N., Moriya J., Yasumura Y., Uematsu M., Ono F., Shimizu W., et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110 (2004) 3674-3679
54. Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 104 (2001) 2034-2038 23
55. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
56. Neary N.M., Small C.J., Wren A.M., Lee J.L., Druce M.R., Palmieri C., et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89 (2004) 2832-2836
57. Orme S.M., McNally R.J., Cartwright R.A., and Belchetz P.E. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83 (1998) 2730-2734
58. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R.L., et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 145 (2001) 669-673
59. Sharma R., and Anker S. First Cachexia Symposium, Berlin, Germany, 1st-2nd December, 2000. Eur J Heart Fail 3 (2001) 751-754
60. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87 (2002) 240-244
61. Shimizu Y., Nagaya N., Isobe T., Imazu M., Okumura H., Hosoda H., et al. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 9 (2003) 774-778
62. Soriano-Guillén L., Barrios V., Campos-Barros A., and Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr 144 (2004) 36-42
63. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 6 (2006) 318-328
64. Strasser F., Lutz T.A., Maeder M.T., Thuerlimann B., Bueche D., Tschöp M., et al. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer 98 (2008) 300-308
65. Tack J., Depoortere I., Bisschops R., Verbeke K., Janssens J., and Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 22 (2005) 847-853
66. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., Yoshimoto A., Harada M., et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85 (2000) 4908-4911
67. Theander-Carrillo C., Wiedmer P., Cettour-Rose P., Nogueiras R., Perez-Tilve D., Pfluger P., et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 116 (2006) 1983-1990
68. Tracey K.J. The inflammatory reflex. Nature 420 (2002) 853-859
69. Tschöp M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
70. Tschöp M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., and Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 50 (2001) 707-709
71. Volante M., Allia E., Fulcheri E., Cassoni P., Ghigo E., Muccioli G., et al. Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. Am J Pathol 162 (2003) 645-654
72. Wang W., Andersson M., Iresjö B.M., Lönnroth C., and Lundholm K. Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia. Int J Oncol 28 (2006) 1393-1400
73. Waseem T., Javaid-Ur-Rehman, Ahmad F., Azam M., and Qureshi M.A. Role of ghrelin axis in colorectal cancer: a novel association. Peptides 29 (2008) 1369-1376
74. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 (2000) 4325-4328
75. Wu R., Dong W., Zhou M., Zhang F., Marini C.P., Ravikumar T.S., et al. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med 176 (2007) 805-813
76. Wynne K., Giannitsopoulou K., Small C.J., Patterson M., Frost G., Ghatei M.A., et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol 16 (2005) 2111-2118
77. Xu X.B., Pang J.J., Cao J.M., Ni C., Xu R.K., Peng X.Z., et al. GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure. Am J Physiol Heart Circ Physiol 289 (2005) 1643-1651
78. Yeh A.H., Jeffery P.L., Duncan R.P., Herington A.C., and Chopin L.K. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res 11 (2005) 8295-8303
79. Zigman J.M., and Elmquist J.K. Mini review: from anorexia to obesity-the yin and yang of body weight control. Endocrinology 144 (2003) 3749-3756